Grade: Pharmaceutical Grade

Factory Location: Lianyungang Jiangsu China

Main Sales Markets: North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East,Africa

Sample Provided: no

Irinotecan is a drug used for the treatment of cancer. Its main use is in colon cancer, in particular, in combination with other chemotherapy agents. This includes the regimen FOLFIRI, which consists of infusional 5-fluorouracil, leucovorin, and irinotecan.
Irinotecan HCl gets Chinese local GMP certificate and has been approved by US-FDA and Japanese PMDA.
Irinotecan HCl Injection gets Chinese local GMP  certificate and MA issude from US-FDA and Japanese PMDA.